Improving the cellular pertussis vaccine: Increased potency and consistency
Improving the cellular pertussis vaccine: Increased potency and consistency
About this item
Full title
Author / Creator
Publisher
Oxford: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Oxford: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Although Europe, Canada and the US have switched from cellular to acellular pertussis vaccines, most developing countries will continue to use the more cost effective cellular vaccine. Consistency of production however is the typical problem inherent to cellular vaccines. Optimising the production process of cellular pertussis bulk suspensi...
Alternative Titles
Full title
Improving the cellular pertussis vaccine: Increased potency and consistency
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_wageningen_narcis_oai_library_wur_nl_wurpubs_361080
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_wageningen_narcis_oai_library_wur_nl_wurpubs_361080
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2007.11.047
